-
$0
0.0% of portfolio
-
Q2 2024
Reduced 89.51%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 53.47%
$1.04B
$2.14 Million
0.0% of portfolio
92,388
Q2 2024
Added 258.44%
$0
$133,000
0.0% of portfolio
11,589
Q2 2024
Added 32.7%
$0
$151,000
0.0% of portfolio
20,085
Q2 2024
Reduced 0.2%
$180M
$129,000
0.0% of portfolio
6,308
Q2 2024
Reduced 36.84%
$5.82B
$3.29 Million
0.0% of portfolio
34,781
Q2 2024
Reduced 49.52%
$1.27B
$1.64 Million
0.0% of portfolio
119,246
Q2 2024
Added 23.48%
$16.3B
$53.1 Million
0.0% of portfolio
691,934
Q2 2024
Reduced 4.04%
$7.66B
$24.5 Million
0.0% of portfolio
136,339
Q2 2024
Added 70.99%
$909M
$3.74 Million
0.0% of portfolio
124,589
Q2 2024
Reduced 0.66%
$145M
$87,000
0.0% of portfolio
2,986
Q2 2024
Added 78.59%
$354M
$494,000
0.0% of portfolio
10,866
Q2 2024
Added 30.88%
$208M
$575,000
0.0% of portfolio
36,086
Q2 2024
Added 89.36%
-
$0
0.0% of portfolio
-
Q2 2024
Added 1,800.0%
$1.45B
$2.58 Million
0.0% of portfolio
120,533
Q2 2024
Added 19.91%
$951M
$4.29 Million
0.0% of portfolio
263,819
Q2 2024
Added 11.81%
$2.63B
$21.6 Million
0.0% of portfolio
288,990
Q2 2024
Reduced 6.28%
$282M
$234,000
0.0% of portfolio
80,951
Q2 2024
Added 37.69%
$2.18B
$13.5 Million
0.0% of portfolio
1,726,904
Q2 2024
Added 8.8%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 35.2%
$186M
$92,000
0.0% of portfolio
9,135
Q2 2024
Added 96.62%
$106M
$0
0.0% of portfolio
66
Q2 2024
New
$559M
$209,000
0.0% of portfolio
18,618
Q2 2024
Added 5.35%
$4.09B
$54.5 Million
0.0% of portfolio
3,372,728
Q2 2024
Added 14.65%
$619M
$208,000
0.0% of portfolio
40,123
Q2 2024
Added 10.31%
$3.36B
$50.9 Million
0.0% of portfolio
1,981,218
Q2 2024
Added 116.96%
$212M
$18,000
0.0% of portfolio
15,507
Q2 2024
Reduced 3.75%
Perspective Therapeutics Inc
-
$0
0.0% of portfolio
-
Q2 2024
New
$768M
$5.37 Million
0.0% of portfolio
1,420,948
Q2 2024
Added 21.16%
$906M
$4.39 Million
0.0% of portfolio
198,976
Q2 2024
Reduced 6.22%
$83.4M
$232,000
0.0% of portfolio
57,488
Q2 2024
Reduced 48.97%
Petros Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q2 2024
Added 5,300.0%
$0
$1.62 Million
0.0% of portfolio
136,180
Q2 2024
Added 16.46%
$0
$4.82 Million
0.0% of portfolio
374,061
Q2 2024
Added 7.54%
$0
$90,000
0.0% of portfolio
5,898
Q2 2024
Added 0.25%
$34.9M
$0
0.0% of portfolio
152
Q2 2024
Added 181.48%
$718M
$115,000
0.0% of portfolio
6,121
Q2 2024
Reduced 21.61%
$636M
$1.01 Million
0.0% of portfolio
98,032
Q2 2024
Reduced 7.39%
$496M
$700,000
0.0% of portfolio
41,781
Q2 2024
Added 53.67%
$4.33B
$10.8 Million
0.0% of portfolio
329,714
Q2 2024
Reduced 5.47%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 50.73%
Phio Pharmaceuticals Corp
-
$0
0.0% of portfolio
-
Q2 2024
New
$13.4M
$0
0.0% of portfolio
125
Q2 2024
New
$1.47B
$2.48 Million
0.0% of portfolio
100,693
Q2 2024
Reduced 10.5%
$1.07B
$9.19 Million
0.0% of portfolio
433,318
Q2 2024
Reduced 2.05%
-
$0
0.0% of portfolio
-
Q2 2024
New
$135M
$101,000
0.0% of portfolio
31,171
Q2 2024
Reduced 5.84%
$207M
$740,000
0.0% of portfolio
74,198
Q2 2024
Reduced 12.33%
$879M
$5.48 Million
0.0% of portfolio
756,284
Q2 2024
Added 4.1%